TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11058672

Group type: EXPERIMENTAL
Intervention: Inhaled zanamivir (10 mg twice a day for 5 days for index cases, 10 mg once a day for 10 days for family members)
Number of subjects: 1158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1158

Group type: EXPERIMENTAL
Intervention: Inhaled zanamivir
Number of subjects: 1158
Study: 8826739

Group type: EXPERIMENTAL
Intervention: VHF + RT
Number of subjects: 73

Group type: COMPARATOR
Intervention: RT
Number of subjects: 73
Study: 1411408

Group type: EXPERIMENTAL
Intervention: Ramipril (5 mg/d)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Nitrendipine (20 mg/d)
Number of subjects: 52
Study: 3914703

Group type: EXPERIMENTAL
Intervention: Piroxicam 20 mg/qd
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sulindac 200 mg twice a day
Number of subjects: 49
Study: 31251548

Group type: EXPERIMENTAL
Intervention: Kamedis Eczema Therapy Cream (tested product)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Leading OTC brand (comparator)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 108
Study: 28918674

Group type: EXPERIMENTAL
Intervention: 150 mg Fruitflow®
Number of subjects: 12
Study: 26177151

Group type: EXPERIMENTAL
Intervention: Core stability training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (standard warm-up)
Number of subjects: 20
Study: 25284142

Group type: EXPERIMENTAL
Intervention: Transoral fundoplication (TF)
Number of subjects: 63

Group type: COMPARATOR
Intervention: High-dose proton-pump inhibitors (HD PPIs)
Number of subjects: 63
Study: 22409309

Group type: EXPERIMENTAL
Intervention: Eltrombopag (12.5 mg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Eltrombopag
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 20174834

Group type: EXPERIMENTAL
Intervention: landiolol 0.1 mg/kg
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: nicardipine 0.02 mg/kg
Number of subjects: 180

Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 180
Study: 18472103

Group type: EXPERIMENTAL
Intervention: Pitavastatin 2 mg
Number of subjects: 251

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 251
Study: 16018750

Group type: EXPERIMENTAL
Intervention: Vitamin-B complex supplementation (50 mg of thiamine HCl, riboflavin, niacinamide, d-calcium pantothenate, pyridoxine HCl; 50 microg each of d-biotin and cyanocobalamin; and 400 mcg of folate) for 30 days after AFS
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vitamin-B complex supplementation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vitamin-B complex supplementation and placebo
Number of subjects: 30
Study: 12454519

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy (Group B)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Adjuvant locoregional chemoimmunotherapy (Group C)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Surgical resection alone (Group A)
Number of subjects: 128
Study: 10609206

Group type: EXPERIMENTAL
Intervention: Increased atmospheric pressure (hyperbaric chamber for 1 hour)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (age and sex matched eyes without RK)
Number of subjects: 8
Study: 7499110

Group type: EXPERIMENTAL
Intervention: Sulofenur 640 mg/M2
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sulofenur 800 mg/M2
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sulofenur 960 mg/M2
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sulofenur (all dosages)
Number of subjects: 13
Study: 1959341

Group type: EXPERIMENTAL
Intervention: Calcium carbonate (CaCO3) 6 g/day for 3 months
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 6765542

Group type: EXPERIMENTAL
Intervention: Human insulin combination with 20% regular and 80% NPH
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Human insulin combination with 30% regular and 70% NPH
Number of subjects: 10

Group type: COMPARATOR
Intervention: PPI 30/70 combination
Number of subjects: 10
Study: 31600414

Group type: EXPERIMENTAL
Intervention: Internet-delivered mindfulness-based cognitive therapy (iMBCT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Care-as-usual (CAU) wait-list
Number of subjects: 150
Study: 31119881

Group type: EXPERIMENTAL
Intervention: Daily self-weighing (DSW) with visual graphical feedback (GF)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 111
Study: 28635352

Group type: EXPERIMENTAL
Intervention: OB/Mobius® retractor
Number of subjects: 154

Group type: COMPARATOR
Intervention: Conventional retraction instruments
Number of subjects: 154
Study: 25919921

Group type: EXPERIMENTAL
Intervention: SmartLoss
Number of subjects: 40

Group type: COMPARATOR
Intervention: Health Education
Number of subjects: 40
Study: 24086658

Group type: EXPERIMENTAL
Intervention: Bright white light (10,000 lux)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dim red light (< 500 lux)
Number of subjects: 0
Study: 21843968

Group type: EXPERIMENTAL
Intervention: Vitrified sibling oocytes
Number of subjects: 31

Group type: COMPARATOR
Intervention: Fresh sibling oocytes
Number of subjects: 31
Study: 20108207

Group type: EXPERIMENTAL
Intervention: 800 microg/day of folic acid (verum)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 16395260

Group type: EXPERIMENTAL
Intervention: FK352 (50 mg, intravenous)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: FK352
Number of subjects: 30
Study: 15085364

Group type: EXPERIMENTAL
Intervention: BNP measurements
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dyspnea score
Number of subjects: 100
Study: 10935580

Group type: EXPERIMENTAL
Intervention: Hypotensive anesthesia
Number of subjects: 23

Group type: COMPARATOR
Intervention: Normotensive anesthesia
Number of subjects: 23
Study: 9008601

Group type: EXPERIMENTAL
Intervention: Recombinant interferon-gamma (rIFN gamma) 50 micrograms subcutaneously over 24 weeks
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo injections at the same time frequency
Number of subjects: 197
Study: 8497357

Group type: EXPERIMENTAL
Intervention: Standard skin preparation plus normal saline irrigation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Standard preparation plus antibiotic irrigation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Special preparation plus normal saline irrigation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Special preparation plus antibiotic irrigation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Povidone-iodine alone
Number of subjects: 100
Study: 2887615

Group type: EXPERIMENTAL
Intervention: Famotidine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cimetidine or Ranitidine
Number of subjects: 32
Study: 31571089

Group type: EXPERIMENTAL
Intervention: Microemulsion of fatty acids of the ω‐3 series
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hyaluronic acid (0.15%)‐based tear substitute
Number of subjects: 40
Study: 28922936

Group type: EXPERIMENTAL
Intervention: Relaxation
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Worry
Number of subjects: 189

Group type: COMPARATOR
Intervention: Neutral thinking
Number of subjects: 189
Study: 28660739

Group type: EXPERIMENTAL
Intervention: 12 SQ HDM sublingual immunotherapy tablet
Number of subjects: 395
Study: 25694217

Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg/day) for 6 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 16
Study: 23775581

Group type: EXPERIMENTAL
Intervention: Deferasirox (mean dose 9.8 ± 3.6 mg/kg/day)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Deferasirox (mean dose in extension 13.7 ± 4.6 mg/kg/day)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Deferasirox
Number of subjects: 130
Study: 21361981

Group type: EXPERIMENTAL
Intervention: Negative feedback
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Positive feedback
Number of subjects: 2

Group type: COMPARATOR
Intervention: Consistency-driven responses
Number of subjects: 2
Study: 19032121

Group type: EXPERIMENTAL
Intervention: FFNS 110 microg
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: FFNS 220 microg
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 16575712

Group type: EXPERIMENTAL
Intervention: Enhanced Outpatient Physiotherapy (EAP)
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Outpatient Rehabilitation (AR)
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Medical Training Therapy (MTT)
Number of subjects: 1274

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1274
Study: 15353533

Group type: EXPERIMENTAL
Intervention: Undiluted APSV
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: 1:5 dilution APSV
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: 1:10 dilution APSV
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 340
Study: 11851735

Group type: EXPERIMENTAL
Intervention: Rehabilitation (physiotherapy, casting, strengthening, and/or orthoses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spasticity management (intramuscular injections of phenol, alcohol, and botulinum toxin type A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orthopaedic approaches
Number of subjects: 0
Study: 9517912

Group type: EXPERIMENTAL
Intervention: Milnacipran (50 mg twice daily)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Imipramine (50 mg twice daily)
Number of subjects: 219
Study: 8044618

Group type: EXPERIMENTAL
Intervention: Ivalon sponge rectopexy
Number of subjects: 63

Group type: COMPARATOR
Intervention: Sutured rectopexy
Number of subjects: 63
Study: 3403888

Group type: EXPERIMENTAL
Intervention: Base-in prism lenses
Number of subjects: 48

Group type: COMPARATOR
Intervention: Plano lenses
Number of subjects: 48
Study: 30423810

Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve
Number of subjects: 0
Study: 28054312

Group type: EXPERIMENTAL
Intervention: Placebo Galvanic Vestibular Stimulation (GVS) pre-exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deceptive pre-exposure to placebo stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Open pre-exposure to placebo stimulation
Number of subjects: 0
Study: 26271700

Group type: EXPERIMENTAL
Intervention: Epsorin (main study group)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Traditional treatment (control group)
Number of subjects: 84
Study: 22713081

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine (CHX) gel and 304% fluoride toothpaste
Number of subjects: 199

Group type: COMPARATOR
Intervention: Control group (twice daily toothbrushing with toothpaste only)
Number of subjects: 199
Study: 21693007

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Prednisolone plus acute stage acupuncture
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Placebo prednisolone plus acute stage acupuncture
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Prednisolone plus resting stage acupuncture
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Placebo prednisolone plus resting stage acupuncture
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Prednisolone plus acupuncture
Number of subjects: 1200
Study: 18971385

Group type: EXPERIMENTAL
Intervention: FES plus conventional occupational and physiotherapy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Only conventional therapy (control group)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Only FES therapy (chronic group)
Number of subjects: 21
Study: 16776696

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 12588577

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: HCTZ 12.5 mg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: HCTZ 25 mg
Number of subjects: 320
Study: 11147378

Group type: EXPERIMENTAL
Intervention: Standard surgical tracheostomy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Percutaneous dilatational tracheostomy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Translaryngeal tracheostomy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Surgical tracheostomy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All three groups
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All three techniques
Number of subjects: 30
Study: 9496386

Group type: EXPERIMENTAL
Intervention: Epirubicin monotherapy every two weeks (110 mg/m2) with filgrastim (5 micrograms/kg/daily) prophylactically on days 2‐12 of each cycle
Number of subjects: 167

Group type: COMPARATOR
Intervention: Epirubicin monotherapy every four weeks (110 mg/m2) with filgrastim (5 micrograms/kg/daily) prophylactically on days 2‐12 of each cycle
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Epirubicin monotherapy every two weeks
Number of subjects: 167

Group type: COMPARATOR
Intervention: Epirubicin monotherapy every four weeks
Number of subjects: 167
Study: 8369939

Group type: EXPERIMENTAL
Intervention: Single-dose cefuroxime (1.5 g intravenously before operation)
Number of subjects: 1004

Group type: COMPARATOR
Intervention: Three-dose cefuroxime regimen (1.5 g before and two doses of 0.75 g after operation)
Number of subjects: 1004
Study: 3734571

Group type: EXPERIMENTAL
Intervention: Modified method of ulnar variance measurement
Number of subjects: 100

Group type: COMPARATOR
Intervention: Palmer method (1982)
Number of subjects: 100
Study: 30326888

Group type: EXPERIMENTAL
Intervention: Non-invasive diabetes risk prediction model (German Diabetes Risk Score) during routine health check.
Number of subjects: 300

Group type: COMPARATOR
Intervention: Routine health check 'Check-up 35' (control group).
Number of subjects: 300
Study: 27576777

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 1230

Group type: COMPARATOR
Intervention: Ticagrelor
Number of subjects: 1230
Study: 24114846

Group type: EXPERIMENTAL
Intervention: Multifaith spiritually based intervention (SBI)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Supportive psychotherapy (SP)
Number of subjects: 23
Study: 22493908

Group type: EXPERIMENTAL
Intervention: Acupuncture and Tuina
Number of subjects: 300

Group type: COMPARATOR
Intervention: Rehabilitation
Number of subjects: 300
Study: 20090676

Group type: EXPERIMENTAL
Intervention: Erythromycin (250 mg oral dosing)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Erythromycin (125 mg intravenous dosing)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Healthy controls (N=12)
Number of subjects: 12
Study: 19391320

Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 16
Study: 15705053

Group type: EXPERIMENTAL
Intervention: Abtronic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feminique
Number of subjects: 0
Study: 12800418

Group type: EXPERIMENTAL
Intervention: Jiawei Mojie Tablet (JMT)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Yueyueshu Granule (Control)
Number of subjects: 63
Study: 11249645

Group type: EXPERIMENTAL
Intervention: MFG‐IRAP gene therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Recombinant IRAP studies
Number of subjects: 0
Study: 8888384

Group type: EXPERIMENTAL
Intervention: Flesinoxan (up to 2.4 mg per day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Flesinoxan (0.6 or 1.2 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Flesinoxan
Number of subjects: 20
Study: 1804665

Group type: EXPERIMENTAL
Intervention: Oral prednisolone 40 mg.day-1
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate 500 micrograms t.d.s.
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 6358156

Group type: EXPERIMENTAL
Intervention: Irradiation combined with misonidazole (1 gr/m2, total dose 12 gr/m2)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Irradiation with placebo
Number of subjects: 100
Study: 30782867

Group type: EXPERIMENTAL
Intervention: Cell salvage
Number of subjects: 3028

Group type: COMPARATOR
Intervention: Standard care without salvage
Number of subjects: 3028
Study: 29386515

Group type: EXPERIMENTAL
Intervention: Infliximab 5mg/kg
Number of subjects: 31

Group type: COMPARATOR
Intervention: IV polyethylene glycol-treated human immunoglobulin (VGIH) 2g/kg
Number of subjects: 31
Study: 26952645

Group type: EXPERIMENTAL
Intervention: Internet Cognitive Behavioral Therapy (MumMoodBooster program)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 43
Study: 24882775

Group type: EXPERIMENTAL
Intervention: Lecture and practice sessions with standardized patients (SPs)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Lecture only
Number of subjects: 94
Study: 22452807

Group type: EXPERIMENTAL
Intervention: Intravenous glucose-insulin-potassium (GIK)
Number of subjects: 871
Study: 21044434

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) in combination with other DMARDs (e.g., leflunomide, cyclosporine, azathioprine, sulfasalazine, gold, hydroxychloroquine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methotrexate (MTX) monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early use of biologics
Number of subjects: 0
Study: 17406019

Group type: EXPERIMENTAL
Intervention: Information presentation methods designed to ease cognitive burden
Number of subjects: 3

Group type: COMPARATOR
Intervention: Standard information presentation methods
Number of subjects: 3
Study: 15774255

Group type: EXPERIMENTAL
Intervention: Suprapubic Arch sling (SPARC)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Tension-free Vaginal Tape (TVT)
Number of subjects: 84
Study: 11916808

Group type: EXPERIMENTAL
Intervention: S(+)‐ketamine (0.5 mg/kg bolus before incision, followed by 2 microg x kg(‐1) x min(‐1) infusion until 2 h after emergence from anesthesia)
Number of subjects: 30

Group type: COMPARATOR
Intervention: NaCl (Control group)
Number of subjects: 30
Study: 11092992

Group type: EXPERIMENTAL
Intervention: E15NL (vitamin‐E‐coated ‐ Terumo)
Number of subjects: 20

Group type: COMPARATOR
Intervention: EE15NL (vitamin‐E‐coated ‐ Terumo)
Number of subjects: 20
Study: 9104982

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass
Number of subjects: 80

Group type: COMPARATOR
Intervention: No cardiopulmonary bypass (control group)
Number of subjects: 80
Study: 1549961

Group type: EXPERIMENTAL
Intervention: Alendronate, 10 mg/day for 5 days
Number of subjects: 15
Study: 3925746

Group type: EXPERIMENTAL
Intervention: Intravenous isosorbide dinitrate (ISDN)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Intravenous nitroglycerin (NTG)
Number of subjects: 67
Study: 29316157

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 26561408

Group type: EXPERIMENTAL
Intervention: Food basket without education
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Food basket with education
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Cash transfer with education
Number of subjects: 145
Study: 25073063

Group type: EXPERIMENTAL
Intervention: Experimental group (High SOC)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Experimental group (Low SOC)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (High trait anxiety)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (Low trait anxiety)
Number of subjects: 150
Study: 22572916

Group type: COMPARATOR
Intervention: Single-session intervention (40-minute in-person, literacy-sensitive training)
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Multisession intervention (initial training plus ongoing telephone-based support)
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Multisession intervention
Number of subjects: 605
Study: 20683351

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) warm-up
Number of subjects: 22

Group type: COMPARATOR
Intervention: Dry swings (DS)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: WBV with dry swings (WBVDS)
Number of subjects: 22
Study: 19050436

Group type: EXPERIMENTAL
Intervention: Intraarterial autologous BMCs with oral antioxidants and L-arginine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Maximal drug therapy (control group)
Number of subjects: 18
Study: 16189765

Group type: EXPERIMENTAL
Intervention: CT colonography
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional colonography
Number of subjects: 100
Study: 12934760

Group type: EXPERIMENTAL
Intervention: Walnut oil (3 g/day in 500 mg capsules) for 45 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 60
Study: 10651694

Group type: EXPERIMENTAL
Intervention: Short course therapy (multiple courses of 12 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Continuous therapy (1 year)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both short course and continuous therapy
Number of subjects: 40
Study: 8880657

Group type: EXPERIMENTAL
Intervention: Behavioral marital therapy (BMT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Interactional couples therapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Individual counseling alone
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: BMT plus individual counseling
Number of subjects: 36

Group type: COMPARATOR
Intervention: All three treatments (BMT, interactional therapy, individual counseling)
Number of subjects: 36
Study: 1668960

Group type: EXPERIMENTAL
Intervention: 400 mg acyclovir t.d. for 6 months
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 31567839

Group type: EXPERIMENTAL
Intervention: Static Stretching (SS) for 80 seconds
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Dynamic Stretching (DS) for 80 seconds
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (CON) with no stretching
Number of subjects: 45
Study: 29976939

Group type: EXPERIMENTAL
Intervention: Morningness group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Social jetlag influence
Number of subjects: 24
Study: 27973619

Group type: EXPERIMENTAL
Intervention: Metformin 1000 mg/d
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Metformin 500 mg/d
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55